1. Introduction
Glaucoma derives from an increase of the intra-ocular pressure (IOP) due to accumulation of the aqueous humor which causes degenerative events at the level of the retina and the optic nerve. This results in a progressive damage of the optic nerve that is paralleled by the gradual loss of retinal ganglion cells (RGC). The pathology causes increasing eyesight deterioration particularly in the peripheral areas of the visual field. The optic nerve papilla becomes paler and shows an augmented excavation as compared with a normal physiological situation. The increase of the IOP is to be ascribed, in the majority of cases, to an alteration of the ocular hydrodynamics: in particular the normal efflux of aqueous humor from the anterior chamber of the eye is severely hindered. The drainage system is located in the limbal regions or in the sclero-corneal junction. The inner surface presents a hollow (depression) known as inner scleral spur which is filled by the trabecular meshwork and the canal of Schlemm. Primary open angle glaucoma is caused by the failure of drainage from the trabecular meshwork, while the primary closed angle glaucoma consists in a modification of the iris-corneal angle. It is commonly accepted that glaucoma is the second cause of blindness in the world; as a matter of fact it has been estimated that 68 millions of patients are affected by this pathology and out of them, about 7 millions suffer complete bilateral blindness as a consequence of the glaucoma. The onset of the disease may occur at any age, also at childhood, but it is significantly more frequent in elderly people. Glaucoma is generally categorized in five different groups; two of them are the above mentioned open and closed angle primary glaucoma which are also the most widespread ones. A broad variety of pathological conditions may induce, as secondary event, the obstruction of the drainage system of the drainage angle which results in glaucoma. The primary open angle, which represents more than 60% of the cases, is a chronic condition. The outflow angle is not altered; the aqueous humor produced by the ciliary body reaches the trabecular meshwork, but its drainage is not efficient. This is possibly due to the decrease of diffusion towards the Schlemm’s canal which causes a continuing increase of the IOP ending in the progressive degeneration of the optic nerve. Among the secondary factors contributing to the insurgence of glaucoma one should take into account: age (above 70), myopia and ethnic origin since the African populations seem to be more prone to develop the disease.
In the primary closed angle glaucoma which occurs in about 10% of patients, a closure of the filtration angle in the eye is observed and this is occasionally due to the trabecular obstruction by the iris. The mode of insurgence of this type of glaucoma, unlike other forms, is very rapid and is therefore also known as acute glaucoma. In this condition one of the main risk factors is also associated to familial and/or ethnic factors. As a matter of fact, East asian populations, the Chinese one in particular, show a significant aptitude towards this pathology, other risk factors being the patient’s age (above 50 years of age the incidence of the pathology increases) and hypermetropia. To date a decisive therapy for neither open nor closed angle glaucoma is available, however some treatments exist allowing the slowing, and in some cases the arrest, of the progression of the disease.
Secondary glaucoma may develop as a consequence of other pathologies such as inflammation, cataract, traumas, pigments released from the iris and, finally, tumors. In this situation the eye activates its defense producing the hyper-secretion of aqueous humor thus leading to ocular hypertension. One of the main characteristics of glaucoma is the increased excavation of the optic disk which extends towards its margins. Even though some studies support the idea that the pathology may start at retinal level, some indications exist that the early lesions occur at the level of the head of the optic nerve, in particular on the
Hypotheses on the mechanisms of cell degeneration are diverse, the mechanical stress and the ischemic model being two of the most corroborated ones. The mechanical stress theory purports that the increase of the IOP within the anterior chamber causes a direct hyper-pressure at the retina-vitreous interface. This mechanical stress would directly trigger cell death by physical compression. According to this theory the mechanical insult causes modifications of the cell function: with respect to this, it has been reported that this type of insult may alter gene expression in organs such as the heart and the endothelial vessels. Furthermore, by the activation of transduction pathways, different functional responses are induced in retinal cells and astrocytes [4]. This IOP-induced mechanical stress could also inhibit the retrograde transport along the ganglion cell axons. Regarding this particular point, it has been observed a block in the axonal transport at the level of the
The ischemic hypothesis postulates that the high intraocular pressure and the deformation of the
The glaucoma neuropathy may be also due to an insufficient vascular perfusion of the optic nerve which causes an ischemic damage to this organ. The ischemia thus generated, ends in an oxidative stress at RGC level and causes apoptotic death. This phenomenon happens because when re-perfusion initiates, the presence of oxygen in the tissue exposed to ischemia, induces the formation of radical oxygen species (ROS). When the concentration of ROS is too high, the anti-oxidant systems of the cell become unable to inactivate them, due to a deficient homeostasis, thus the free radicals are no longer neutralized and may cause cell death either via apoptosis or necrosis. In conclusion both types of stress, the mechanical and the ischemic one, can contribute to the establishment of the disease [2].
1.1. Cellular targets of the ocular hypertension
A complex interaction between neural and glial cells exists during the differentiation and the life of the nervous system. As a matter of fact, neuroglia cells maintain the normal functions of the nervous system since they control the extra cellular environment, block the toxic agents and supply the trophic resources and, last but not least, provide a structural support to the neurons. In glaucoma, astrocytes play a very important role as far as the re-modeling of the
1.2. Oxidative stress and retinal ganglion cell death in glaucoma
Oxidative stress is initiated by the imbalance between the production of ROS and their elimination by antioxidants. This phenomenon plays a key role in neuronal damage ending with neuron death which usually occurs by apoptosis. These reactive oxygen species are produced by mitochondria but can also derive from enzymatic degradation of neurotransmitters, neuroinflammatory mediators, and redox reactions [7]. Mitochondrial dysfunction can result in an increased level of ROS which is often found in neurodegenerative pathologies. Abnormal protein folding, defective ubiquitination and proteasome degradation systems may cause the production of ROS [8]. This promotes neuronal death
Apart from the elevated intraocular pressure, other risk factors such as genetic background, decreased corneal thickness, age and vascular dys-regulation may play an important role in the insurgence of glaucoma [32 - 39]. However, even if these factors may determine a risk to develop the disease, it remains difficult to establish a cause/effect relationship to develop this pathology: actually, one should consider that a high intraocular pressure is common among open-angle patients but many individuals showing this sign eventually will not develop glaucoma [40]. A further apparently paradoxical phenomenon is that a significant number of glaucoma patients progressively lose vision even though they react positively to drugs lowering the IOP [41 - 44]. In conclusion the cause of RGC in glaucoma still remains to be fully elucidated. Certainly the understanding of the apoptic death in RGC determined by the pathology is to be ascribed to the high complexity and the multifactorial character of the disease. The development of new neuroprotective therapies, even though will give a scant contribution to the elucidation of the molecular and cellular mechanisms underlying the disease, will certainly help to slow the development and progression of the pathology in glaucoma patients.
1.3. Mitochondrial malfunctions and ophthalmogical diseases
The association of ophthalmologic diseases to a mitochondrial etiology is assuming an increasingly interest: many authors consider, as a matter of fact, that the pathologies originate from impaired mitochondrial function, oxidative stress and enhanced apoptotic death. The mitochondrial role in the development of primary congenital glaucoma, characterized by trabecular dysgenesis, has been recently suggested. The formation of the trabecular meshwork during development is thought to have particular sensitivity to oxidative stress induced damage. Mitochondrial DNA (mtDNA) mutations, in particular, are emerging as causative agents of ophthalmologic disorders affecting mostly the optic nerve and the retina as well as the extra-ocular muscles. Also in these cases antioxidant therapy represents a good tool to treat these ophthalmologic conditions. Mitochondrial dysfunction is suggested, for example, to play an important role in age related macular degeneration, glaucoma and diabetes dependant retinopathy. Some biomarkers have been identified in the mitochondrial oxidative stress response: for instance, prohibitins also known as PHB may have diverse functions and are also involved in mitochondrial structure and functionality. These proteins present a ring-like structure with 16–20 alternating Phb1 and Phb2 subunits in the inner mitochondrial membrane [45]. The precise molecular function of the PHB molecular complex is not clear even though it has been hypothesized that they may have a role as chaperone for respiration chain proteins or as providers of a scaffold for the optimal mitochondrial morphology and function. Prohibitins have been demonstrated to stimulate cell proliferation both in plants and mammals such as rodents. As far as tissue re-modeling is concerned, the proteins of the matrix metalloproteinase (MMP) family could be a useful tool in gene therapy aimed at the protection/rescue of the RGCs. Therefore PHB and MMP could constitute an effective biomarker and/or a therapeutic target for ophthalmologic pathologies. (For a recent review see [46]).
2. A model of experimental glaucoma in rat
Several experimental animal models exist to investigate the ocular pathologies. In our laboratory we have developed a rat model of hypertension that mimics and reproduces the situation found in human glaucoma. This animal model will be briefly reviewed in the following sections [2].
2.1. Induction of the intra-ocular hypertension
To induce ocular hypertension
2.2. Lipoperoxidative damage of the membrane and apoptosis after induction of cell stress
The data obtained in our laboratory support the idea that ocular hypertension causes apoptotic death of retinal ganglion cells and over-expression of molecular markers typical of oxidative cell stress response and apoptosis. Glial cells may have a neuroprotective role in a pathological situation; in any case they may contribute protection from neuron damage. In particular, during progression of glaucoma, astrocytes are involved in the re-modeling of the
3. Conclusions
In conclusion, literature data imply that the RGCs are one of the main targets of the oxidative stress in the neural tissue. As shown in our studies, the injection of methylcellulose into the anterior chamber of the eye activates diverse signals of stress at the level of RGCs. Mainly, the up-regulation of the GFAP and DNA damage become evident. Methylcellulose hinders the efflux of fluids from the canals of Schlemm thus increasing the IOP. The consequent oxidative stress is shown by the overexpression of iNOS, which is an enzyme primarily involved in the mitochondrial lipid peroxidation, with consequent damage of the cell membrane. This is validated by the accumulation of intracellular malonal-dihaldehyde: a hallmark of lipoperoxidation. The ubiquitin-mediated proteasome pathway is also activated and this is directly related to the execution of the apoptotic death. The antiapoptotic role of carnitine plays a key role in the stabilization and function of the cell membrane, the mitochondrial one in particular. The contemporary treatment with methylcellulose and carnitine reduces the level of typical markers of cell sufferance and apoptotis, this enhances the mitochondrial performance, improves the overall homeostatic response to the hypertensive insult, and limits the apoptotic phenomena.
References
- 1.
Apoptosi nel glaucoma. In: Apoptosi in oftalmologia, Ed I.N.C.Capaccioli S Nucci C Quattrone A Carella E 1998 44 57 - 2.
Degenerative and apoptotic events at retinal and optic nerve level after experimental induction of ocular hypertension. Mol Cell Biochem,Calandrella N Scarsella G Pescosolido N Risuleo G 2007 301 155 163 - 3.
Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am. J. OphthalmolQuigley H. A Dunkelberger G. R Green W. R 1989 107 453 464 - 4.
Responses of different cells lines from ocular tissues to elevated hydrostatic pressure. Br. J. OphthalmolWax M. B Tezel G Kobayashi S Hernandez M. R 2000 84 423 428 - 5.
Retrograde axonal trasport of BDNF in retinal ganglion cell is blocked by acute IOP elevation in rat. Invest. Ophthalmol. Vis. Sci.Quigley H. A Mckinnon S. J Zack D. J Pease M. E Kerrigan-baumrind L. A Kerrigan F. D Mitchell R. S 2000 41 3460 3466 - 6.
Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage. EyeMorgan J. E 2000 14 437 444 - 7.
Oxidative stress and neurodegeneration: where are we now? J. Neurochem.Halliwell B 2006 97 1634 1658 - 8.
Oxidative stress in neurodegeneration: cause or consequence? Nat. Med.Andersen J. K 2004 5 18 25 - 9.
Thiol oxidation of cell signaling proteins: controlling an apoptotic equilibrium. J. Cell. Biochem.Cross J. V Templeton D. J 2004 93 104 111 - 10.
Lipid peroxidation in open-angle glaucoma. Acta Ophthalmol. (Copenh)Babizhayev M. A Bunin A 1989 67 371 77 - 11.
Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am. J. Med.Izzotti A Saccà S. C Cartiglia C De Flora S 2003 114 638 646 - 12.
Dynamic changes in reactive oxygen species and antioxidant levels in retinas in experimental glaucoma. Free Radic. Biol. Med.Ko M. L Peng P. H Ma M. C Ritch R Chen C. F 2005 39 365 373 - 13.
Rosenstein R Retinal oxidative stress induced by high intraocular pressure. Free Radic. Biol. Med.Moreno M Campanelli J Sande P Snez D Keller-sarmiento M 2004 37 803 812 - 14.
Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch. Ophthalmol.Sacc S Pascott A Camicione P Capris P Izzotti A 2005 123 458 463 - 15.
Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma. Invest. Ophthalmol. Vis. Sci.Tezel G Yang X Cai J 2005 46 3177 3187 - 16.
Carnitine reduces the lipo-peroxidative damage of the membrane and apoptosis after induction of cell stress in experimental glaucoma. Cell Death Dis.Calandrella N De Seta C Scarsella G Risuleo G 2010 e 62. - 17.
Reduced redox state allows prolonged survival of axotomized neonatal retinal ganglion cells. NeuroscienceGeiger L. K Kortuem K. R Alexejun C Levin L. A 2002 109 635 642 - 18.
Superoxide is an associated signal for apoptosis in axonal injury. BrainKanamori A Catrinescu M. M Kanamori N Mears K. A Beaubien R Levin L. A 2010 133 2612 2625 - 19.
Retinal ganglion cell axotomy induces an increase in intracellular superoxide anion. Invest. Ophthalmol. Vis. Sci.Lieven C. J Schlieve C. R Hoegger M. J Levin L. A 2006 47 1477 1485 - 20.
Amplification of a reactive oxygen species signal in axotomized retinal ganglion cells. Antioxid. Redox Signal.Nguyen S. M Alexejun C. N Levin L. A 2003 5 629 634 - 21.
Neuroprotective effect of sulfhydryl reduction in a rat optic nerve crush model. Invest. Ophthalmol. Vis. Sci.Swanson K. I Schlieve C. R Lieven C. J Levin L. A 2005 46 3737 3741 - 22.
The role of oxidative stress in glaucoma. Mutat. Res.Izzotti A Bagnis A Sacc S 2006 612 105 114 - 23.
Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog. Retin. Eye Res.Tezel G 2006 5 490 513 - 24.
Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J. Biol. Chem.Chandel N. S Mcclintock D. S Feliciano C. E Wood T. M Melendez J. A Rodriguez A. M Schumacker P. T 2000 275 25130 25138 - 25.
Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J. Biol. Chem.Duranteau J Chandel N. S Kulisz A Shao Z Schumacker P. T 1998 273 11619 11624 - 26.
An update on the role of free radicals and antioxidant defense in human disease. Int. J. Clin. Lab. Res.Vendemiale G Grattagliano I Altomare E 1999 29 49 55 - 27.
Superoxide dismutase isoenzymes in the human eye. Invest. Ophthalmol. Vis. Sci.Behndig A Svensson B Marklund S. L Karlsson K 1998 39 471 475 - 28.
[28] Effect of age on superoxide dismutase activity of human trabecular meshwork. Invest. Ophthalmol. Vis. Sci.De La Paz M. A Epstein D. L 1996 37 1849 1853 - 29.
Vicinal disulfide turns. Protein Eng.Carugo O Cemazar M Zahariev S Hudaky I Gaspari Z Perczel A Pongor S 2003 16 637 639 - 30.
Adjacent cysteine residues as a redox switch. Protein Eng.Park C Raines R. T 2001 14 939 942 - 31.
Cueva Vargas J.L., Di Polo A. The molecular basis of retinal ganglion cell death in glaucoma. Prog Retin Eye ResAlmasieh M Wilson A. M Morquette B 2012 31 152 181 - 32.
The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration. Am. J. Ophthalmol.Agis I 2000 130 429 440 - 33.
[33] The Ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch. Ophthalmol.Gordon M Beiser J Brandt J Heuer D Higginbotham E Johnson C Keltner J Miller J Parrish R. N Wilson M Kass M 2002 120 714 720 - 34.
EMGT Group. Predictors of long-term progression in the early manifest glaucoma trial. OphthalmologyLeske M. C Heijl A Hyman L Bengtsson B Dong L Yang Z 2007 114 1965 1972 - 35.
Incidence of open-angle glaucoma: the Barbados eye studies. The Barbados Eye Studies Group. Arch. Ophthalmol.Leske M. C Connell A. M Wu S. Y Nemesure B Li X Schachat A Hennis A 2001 119 89 95 - 36.
Five-year incidence of openangle glaucoma: the visual impairment project. OphthalmologyMukesh B. N Mccarty C. A Rait J. L Taylor H. R 2002 109 1047 1051 - 37.
Genetic risk of primary open-angle glaucoma: populationbased Familial aggregation study. Arch. Ophthalmol.Wolfs R. C. W Klaver C. C. W Ramrattan R. S Van Duijn C. M Hofman A De Jong P. T. V. M 1998 116 1640 1645 - 38.
Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am. J. Ophthalmol.Medeiros F. A Sample P. A Zangwill L. M Bowd C Aihara M Weinreb R. N 2003 136 805 813 - 39.
Ocular perfusion pressure and glaucoma: clinical trial and epidemiologic findings. Curr. Opin. Ophthalmol.Leske M. C 2009 20 73 78 - 40.
An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. Am. J. Ophthalmol.Friedman D. S Wilson M. R Liebmann J. M Fechtner R. D Weinreb R. N 2004 138 19 31 - 41.
Neuroprotection of the optic nerve in glaucoma. Acta Ophthalmol. Scand.Caprioli J 1997 75 364 367 - 42.
Risk factors in ocular hypertension. Eur. J. Ophthalmol.Georgopoulos G Andreanos D Liokis N Papakonstantinou D Vergados J Theodossiadis G 1997 7 357 363 - 43.
Visual field progression in open-angle glaucoma patients presenting with monocular field loss. Trans. Sect. Ophthalmol. Am. Acad. Ophthalmol. Otolaryngol.Harbin T. S Podos S. M Kolker A. E Becker B 1976 8 253 257 - 44.
For the Early Manifest Glaucoma Trial Group,. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch. Ophthalmol.Leske M. C Heijl A Hussein M Bengtsson B Hyman L Komaroff E 2003 121 48 56 - 45.
Formation of Membrane-bound Ring Complexes by Prohibitins in Mitochondria. Mol. Biol. CellTatsuta T Model K Langer T 2005 16 248 259 - 46.
Mitochondrial disorders and the eye. Current Opinion in OphthalmologySchrier S. A Marni J. F 2011 22 325 331 - 47.
Development of experimental chronic intraocular hypertension in the rabbit. Austl Nw Z J OphthalmolZhu M. D Cai F. Y 1992 20 225 234 - 48.
Trolox inhibits apoptosis in irradiated MOLT-4 lymphocytes. FASEB JMcclain D. E Kalinich J. F Ramakrishnan N 1995 9 1345 1354 - 49.
Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharm Exp TherDrize J. H Woodard G Calvery H. O 1944 82 377 390